Bally’s Corporation (NYSE: BALY) eyes evoke plc (LSE: EVOK): why a William Hill deal would reshape UK gambling
Read More Pharma Industry News GRI Bio, Vallon Pharmaceuticals to merge for advancing NKT cell regulators GRI Bio, a privately held clinical stage biotech company, will merge with a wholly-owned subsidiary of Nasdaq-listed Vallon… byRaghuram KadariDecember 15, 2022